Table 2.

Correlation Between Expression of Resistance Proteins and Immunophenotype, WBC, and Age in Childhood ALL at Initial Diagnosis

P-gp MRPLRP
C219 MRK16 MRPm6 MRPr1 LRP56
Immunophenotype  
 Common/preB  2.21 (1.75-2.71) 3.40 (2.52-4.43)  2.24 (1.92-2.60)  2.81 (2.42-3.16) 2.08 (1.78-2.54)  
 T  1.67 (1.48-1.78) 3.11 (2.29-3.97)  2.35 (2.04-2.78)  3.49 (3.15-3.82) 1.49 (1.37-1.65)  
WBC  
 <25/nL  2.29 (1.75-2.81) 3.51 (2.76-4.84)  2.15 (1.90-2.54)  2.96 (2.69-3.35) 2.00 (1.75-2.38)  
 ≥25/nL  1.89 (1.54-2.42) 3.28 (2.34-3.97)  2.35 (2.04-2.67)  2.86 (2.41-3.35) 1.98 (1.53-2.50)  
Age (mo)  
 ≥12-<120 2.20 (1.75-2.63)  3.36 (2.52-4.06)  2.23 (1.92-2.62) 2.86 (2.49-3.34)  2.01 (1.68-2.34)  
 ≥120 1.69 (1.42-2.15)  3.15 (2.26-4.72)  2.37 (2.07-2.62) 3.08 (2.48-3.50)  1.88 (1.57-2.28) 
P-gp MRPLRP
C219 MRK16 MRPm6 MRPr1 LRP56
Immunophenotype  
 Common/preB  2.21 (1.75-2.71) 3.40 (2.52-4.43)  2.24 (1.92-2.60)  2.81 (2.42-3.16) 2.08 (1.78-2.54)  
 T  1.67 (1.48-1.78) 3.11 (2.29-3.97)  2.35 (2.04-2.78)  3.49 (3.15-3.82) 1.49 (1.37-1.65)  
WBC  
 <25/nL  2.29 (1.75-2.81) 3.51 (2.76-4.84)  2.15 (1.90-2.54)  2.96 (2.69-3.35) 2.00 (1.75-2.38)  
 ≥25/nL  1.89 (1.54-2.42) 3.28 (2.34-3.97)  2.35 (2.04-2.67)  2.86 (2.41-3.35) 1.98 (1.53-2.50)  
Age (mo)  
 ≥12-<120 2.20 (1.75-2.63)  3.36 (2.52-4.06)  2.23 (1.92-2.62) 2.86 (2.49-3.34)  2.01 (1.68-2.34)  
 ≥120 1.69 (1.42-2.15)  3.15 (2.26-4.72)  2.37 (2.07-2.62) 3.08 (2.48-3.50)  1.88 (1.57-2.28) 

Values represent the median FI and the 25th and 75th percentiles (in parentheses), which are based on the following number of ALL samples at initial diagnosis: 80 to 90 common/preB, 19 to 20 T-ALL, 40 to 47 WBC <25/nL, 57 to 62 WBC ≥25/nL, 73 to 80 age ≥12 to <120 months, and 25 to 28 age ≥120 months. Common/preB versus T-ALL: C219,P = .001; MRPr1, P < .001; LRP56, P < .001. Age between 12 and 120 months versus ≥120 months: C219, P = .016.

Close Modal

or Create an Account

Close Modal
Close Modal